Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Bladder, Colorectal, Esophageal, Head and Neck, Kidney, Leukemia/Lymphoma, Lung, Melanoma, Multiple Myeloma, Neuroendocrine, Ovarian, Pancreas, Sarcoma, Uterine Cervix
Study Phase
Phase 3
Study Completion Date
April 2009
NCT00330759Uploaded 09-26-2016
Available for Download
PDS UID: Multiple_Amgen_2006_156
A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Subjects With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma.
Files:
PROTOCOL20050244 Protocol Amend 1 REDACTED.pdf
CRFAmgen 20050244 CRF REDACTED.pdf
DATA DICTIONARYAmgen 20050244 DDT.pdf
DATA (COMPARATOR ARM)Amgen 20050244 SAS datasets.zip